Figure 3From: Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class receivedImmune-recovery evaluated as absolute CD4+ T-cell count increase with respect to the baseline. Late immunological outcomes in patients who obtained sustained HIV RNA suppression by year 1: absolute CD4+ T-cell count increase in HCV Ab-negative patients (panel a) and in HCV Ab-positive patients (panel b). Note that for immunological analyses data were cut at month 63 when 30% of the enrolled patients were still under observation.Back to article page